Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels in cell cultures.

The State of European BusinessTech 2024 report from Finch Capital predicts AI as an enabler of innovation in 2025. % ...

Cost savings matter most to UK business leaders when choosing a bank account. A survey conducted by NerdWallet found ...